Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Faught

Showing results (191-200 of 198) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 198 results.
Neurology|April 1, 1993
Felbamate monotherapy for partial-onset seizures: an active-control trialE Faught, R C Sachdeo, M P Remler, et al.
Heart Rhythm|December 13, 2012
Scope and nature of sudden cardiac death before age 40 in Ontario: a report from the cardiac death advisory committee of the office of the chief coronerCaileigh M Pilmer, Bonita Porter, Joel A Kirsh, et al.
International Journal of Molecular Sciences|November 25, 2023
Prostate-Specific Membrane Antigen (PSMA) Expression Predicts Need for Early Treatment in Prostate Cancer Patients Managed with Active SurveillanceElham Ahmadi, Simon Wang, Mohammad Gouran-Savadkoohi, et al.
The New England Journal of Medicine|September 17, 1998
A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study GroupD M Treiman, P D Meyers, N Y Walton, et al.
Clinical Genetics|September 18, 2012
Recurrent mutations in DNAJC5 cause autosomal dominant Kufs diseaseM Cadieux-Dion, E Andermann, P Lachance-Touchette, et al.
Neurology|March 17, 1999
Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizuresS C Schachter, B Vazquez, R S Fisher, et al.
Neurology|April 28, 2004
Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyJ A French, A M Kanner, J Bautista, et al.
Neurology|April 28, 2004
Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyJ A French, A M Kanner, J Bautista, et al.
Pageof 20

Showing results (191-200 of 198) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 198 results.
Neurology|April 1, 1993
Felbamate monotherapy for partial-onset seizures: an active-control trialE Faught, R C Sachdeo, M P Remler, et al.
Heart Rhythm|December 13, 2012
Scope and nature of sudden cardiac death before age 40 in Ontario: a report from the cardiac death advisory committee of the office of the chief coronerCaileigh M Pilmer, Bonita Porter, Joel A Kirsh, et al.
International Journal of Molecular Sciences|November 25, 2023
Prostate-Specific Membrane Antigen (PSMA) Expression Predicts Need for Early Treatment in Prostate Cancer Patients Managed with Active SurveillanceElham Ahmadi, Simon Wang, Mohammad Gouran-Savadkoohi, et al.
The New England Journal of Medicine|September 17, 1998
A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study GroupD M Treiman, P D Meyers, N Y Walton, et al.
Clinical Genetics|September 18, 2012
Recurrent mutations in DNAJC5 cause autosomal dominant Kufs diseaseM Cadieux-Dion, E Andermann, P Lachance-Touchette, et al.
Neurology|March 17, 1999
Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizuresS C Schachter, B Vazquez, R S Fisher, et al.
Neurology|April 28, 2004
Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyJ A French, A M Kanner, J Bautista, et al.
Neurology|April 28, 2004
Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyJ A French, A M Kanner, J Bautista, et al.
Pageof 20